Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,541 | 785 | 99.7% |
| Education | $32.16 | 4 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,677 | 104 | $0 (2024) |
| PFIZER INC. | $936.26 | 90 | $0 (2024) |
| Lilly USA, LLC | $895.84 | 70 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $795.97 | 55 | $0 (2024) |
| Novo Nordisk Inc | $789.97 | 57 | $0 (2024) |
| ABBVIE INC. | $768.12 | 62 | $0 (2024) |
| Amgen Inc. | $677.68 | 38 | $0 (2024) |
| GlaxoSmithKline, LLC. | $603.49 | 50 | $0 (2024) |
| Allergan, Inc. | $351.66 | 49 | $0 (2020) |
| Bayer Healthcare Pharmaceuticals Inc. | $330.08 | 15 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,368 | 90 | ABBVIE INC. ($283.80) |
| 2023 | $1,436 | 91 | ABBVIE INC. ($289.06) |
| 2022 | $1,080 | 71 | Amgen Inc. ($146.70) |
| 2021 | $584.26 | 32 | AstraZeneca Pharmaceuticals LP ($99.10) |
| 2020 | $753.04 | 48 | AstraZeneca Pharmaceuticals LP ($194.06) |
| 2019 | $1,848 | 159 | AstraZeneca Pharmaceuticals LP ($303.82) |
| 2018 | $1,588 | 121 | AstraZeneca Pharmaceuticals LP ($331.86) |
| 2017 | $1,915 | 177 | AstraZeneca Pharmaceuticals LP ($341.47) |
All Payment Transactions
789 individual payment records from CMS Open Payments — Page 3 of 32
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/16/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/13/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: Iron Deficiency Anemia | ||||||
| 05/09/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $5.18 | General |
| Category: NEUROSCIENCE | ||||||
| 05/06/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $8.46 | General |
| Category: NEUROSCIENCE | ||||||
| 05/01/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: Endocrinology | ||||||
| 04/30/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/29/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $11.76 | General |
| Category: ENDOCRINOLOGY | ||||||
| 04/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.76 | General |
| Category: NEUROSCIENCE | ||||||
| 04/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.26 | General |
| Category: NEUROSCIENCE | ||||||
| 04/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $4.71 | General |
| Category: Diabetes | ||||||
| 04/11/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $9.14 | General |
| Category: NEUROSCIENCE | ||||||
| 04/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: NEUROSCIENCE | ||||||
| 03/25/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $22.43 | General |
| Category: Psychology/Psychiatric | ||||||
| 03/21/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $17.69 | General |
| Category: NEUROLOGY | ||||||
| 03/20/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: Respiratory | ||||||
| 03/20/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: Obesity | ||||||
| 03/14/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $7.86 | General |
| Category: NEUROSCIENCE | ||||||
| 03/14/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $3.51 | General |
| Category: NEUROSCIENCE | ||||||
| 03/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.71 | General |
| Category: NEUROSCIENCE | ||||||
| 03/07/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/05/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: Inflammation | ||||||
| 02/19/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: NEUROSCIENCE | ||||||
| 02/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Diabetes | ||||||
| 02/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: NEUROSCIENCE | ||||||
| 02/08/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 31 | 1,969 | 3,393 | $179,423 | $89,437 |
| 2022 | 30 | 2,048 | 3,339 | $169,649 | $86,331 |
| 2021 | 38 | 2,214 | 3,577 | $180,547 | $58,221 |
| 2020 | 38 | 2,269 | 3,801 | $202,586 | $96,440 |
All Medicare Procedures & Services
137 procedure records from CMS Medicare Utilization — Page 6 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99406 | Smoking and tobacco use intermediate counseling, greater than 3 minutes up to 10 minutes | Office | 2020 | 14 | 21 | $525.00 | $306.87 | 58.5% |
| 80048 | Blood test, basic group of blood chemicals | Office | 2020 | 29 | 34 | $612.00 | $286.28 | 46.8% |
| 81003 | Automated urinalysis test | Office | 2020 | 81 | 117 | $585.00 | $254.16 | 43.4% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2020 | 13 | 13 | $520.00 | $232.85 | 44.8% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2020 | 11 | 15 | $420.00 | $224.70 | 53.5% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 12 | 20 | $960.00 | $195.42 | 20.4% |
| 84550 | Uric acid level, blood | Office | 2020 | 19 | 30 | $270.00 | $130.86 | 48.5% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 13 | 13 | $832.00 | $103.10 | 12.4% |
| 84100 | Phosphate level | Office | 2020 | 13 | 18 | $162.00 | $84.69 | 52.3% |
| 82550 | Creatine kinase (cardiac enzyme) level | Office | 2020 | 11 | 13 | $169.00 | $83.59 | 49.5% |
| 85652 | Red blood cell sedimentation rate, to detect inflammation | Office | 2020 | 14 | 14 | $126.00 | $32.93 | 26.1% |
| 94760 | Measurement of oxygen saturation in blood using ear or finger device | Office | 2020 | 12 | 13 | $442.00 | $20.73 | 4.7% |
About Dr. Angela Merrifield, MD
Dr. Angela Merrifield, MD is a Family Medicine healthcare provider based in Johnson City, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/01/2005. The National Provider Identifier (NPI) number assigned to this provider is 1124025408.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Angela Merrifield, MD has received a total of $10,573 in payments from pharmaceutical and medical device companies, with $1,368 received in 2024. These payments were reported across 789 transactions from 50 companies. The most common payment nature is "Food and Beverage" ($10,541).
As a Medicare-enrolled provider, Merrifield has provided services to 8,500 Medicare beneficiaries, totaling 14,110 services with total Medicare billing of $330,429. Data is available for 4 years (2020–2023), covering 137 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Johnson City, TN
- Active Since 07/01/2005
- Last Updated 02/20/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1124025408
Products in Payments
- FARXIGA (Drug) $1,297
- VRAYLAR (Drug) $518.20
- TRULICITY (Drug) $456.36
- Kerendia (Drug) $330.08
- Ozempic (Drug) $273.25
- Aimovig (Biological) $264.53
- TRELEGY ELLIPTA (Drug) $257.46
- CHANTIX (Drug) $224.01
- QULIPTA (Drug) $206.57
- EVENITY (Biological) $204.15
- EMGALITY (Drug) $203.02
- JARDIANCE (Drug) $188.97
- XARELTO (Drug) $180.64
- Rybelsus (Drug) $173.86
- TRADJENTA (Drug) $169.10
- MOUNJARO (Drug) $161.72
- NURTEC ODT (Drug) $161.30
- ANORO (Drug) $158.91
- ELIQUIS (Drug) $150.57
- AIMOVIG (Biological) $147.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Johnson City
Leigh Johnson, M.d, M.D
Family Medicine — Payments: $22,383
Dr. Cameron Shawver, D.o, D.O
Family Medicine — Payments: $15,541
Mr. Jeffrey Hopland, M.d, M.D
Family Medicine — Payments: $11,111
Jane Simpson, Do, DO
Family Medicine — Payments: $10,350
Andrew Becker, D.o, D.O
Family Medicine — Payments: $10,298
Dr. Jeremy Elliott, Do, DO
Family Medicine — Payments: $9,784